Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2024-02-06 00:00:00 ET · period of report 2024-02-02 · accession 0000950170-24-011879 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2024-02-06 | 2024-02-02+ | TYRA | Harris Todd | Pres, CEO, Dir | S - Sale | $16.56 | -100.0K | 1.52M | -6% | -$1.66M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-05 | S | D | 13,817 | $16.97 | 1,502,697 | D | — | — | (F4) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.51 to $17.32. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 2 | Common | Common Stock | 2024-02-02 | S | D | 78,996 | $16.45 | 1,523,701 | D | — | — | (F2) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.9995. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 3 | Common | Common Stock | 2024-02-02 | S | D | 7,187 | $17.04 | 1,516,514 | D | — | — | (F3) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.00 to $17.16. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |